Cargando…

Efficacy of Adjunctive Treatments Added to Olanzapine or Clozapine for Weight Control in Patients with Schizophrenia: A Systematic Review and Meta-Analysis

Objectives. This study was conducted to review systematically adjunctive treatments for weight reduction in patients with schizophrenia and compare efficacies of clinical trials through meta-analysis, so as to provide effective clinical guideline regarding weight control for patients taking atypical...

Descripción completa

Detalles Bibliográficos
Autor principal:	Choi, Yun-Jung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4310265/ https://www.ncbi.nlm.nih.gov/pubmed/25664341 http://dx.doi.org/10.1155/2015/970730

Ejemplares similares

Reduced activity and connectivity of left amygdala in patients with schizophrenia treated with clozapine or olanzapine
por: Mier, Daniela, et al.
Publicado: (2018)

Meta-Analysis of the Efficacy and Safety of Olanzapine versus Clozapine when Treating Senile Dementia
por: Wang, Zongqin, et al.
Publicado: (2022)

Retracted: Meta-Analysis of the Efficacy and Safety of Olanzapine versus Clozapine when Treating Senile Dementia
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Use of olanzapine compared with clozapine for treatment-resistant schizophrenia in a real-world setting: nationwide register-based study
por: Jo, Young Tak, et al.
Publicado: (2021)

Adjunctive treatment with aripiprazole for olanzapine-induced hyperprolactinemia
por: Bise, S., et al.
Publicado: (2022)

Association Between SIRT1, Cytokines, and Metabolic Syndrome in Schizophrenia Patients With Olanzapine or Clozapine Monotherapy
por: Fang, Xinyu, et al.
Publicado: (2020)

Electroconvulsive Therapy Added to Non-Clozapine Antipsychotic Medication for Treatment Resistant Schizophrenia: Meta-Analysis of Randomized Controlled Trials
por: Zheng, Wei, et al.
Publicado: (2016)

Gabapentin adjunctive to risperidone or olanzapine in partially responsive schizophrenia: an open-label pilot study
por: Gabriel, Adel
Publicado: (2010)

Olanzapine as an Adjunct in the Management of Refractory Psychogenic Excoriation With Comorbid Schizophrenia: A Case Report
por: Yeager, Violet, et al.
Publicado: (2020)

Worth the Weight? Olanzapine Prescribing in Schizophrenia. A Review of Weight Gain and Other Cardiometabolic Side Effects of Olanzapine
por: Fitzgerald, Ita, et al.
Publicado: (2021)

Efficacy of Olanzapine in Anxiety Dimension of Schizophrenia: A Systematic Review of Randomized Controlled Trials
por: Crapanzano, Calogero, et al.
Publicado: (2022)

Comparative study of sexual dysfunction and serum prolactin level associated with olanzapine, risperidone, and clozapine in patients with remitted schizophrenia
por: Sathish Kumar, S. V., et al.
Publicado: (2015)

Disrupted sphingolipid metabolism following acute clozapine and olanzapine administration
por: Weston-Green, Katrina, et al.
Publicado: (2018)

Metabolic profiles differences of overweight patients on olanzapine, clozapine and risperidone
por: Liew, Siew Fai, et al.
Publicado: (2021)

Metabolic profiles differences of overweight patients on olanzapine, clozapine and risperidone
por: Liew, Siew Fai, et al.
Publicado: (2021)

Metformin for treatment of clozapine-induced weight gain in adult patients with schizophrenia: a meta-analysis
por: LIU, Zhengrong, et al.
Publicado: (2015)

Paroxetine combined with olanzapine in the treatment of schizophrenia
por: Wang, Ning, et al.
Publicado: (2020)

Combination of Electroconvulsive Therapy and Clozapine in Treatment-Resistant Schizophrenia
por: Kim, Jung Hyun, et al.
Publicado: (2018)

Adjunctive Lurasidone Suppresses Food Intake and Weight Gain Associated with Olanzapine Administration in Rats
por: Reynolds, Gavin P., et al.
Publicado: (2019)

Meta-analysis: the effects of smoking on the disposition of two commonly used antipsychotic agents, olanzapine and clozapine
por: Tsuda, Yoshiyuki, et al.
Publicado: (2014)

A commentary on the efficacy of olanzapine for the treatment of schizophrenia: the past, present, and future
por: Citrome, Leslie, et al.
Publicado: (2019)

CoMET: a randomised controlled trial of co-commencement of metformin versus placebo as an adjunctive treatment to attenuate weight gain in patients with schizophrenia newly commenced on clozapine
por: Siskind, Dan, et al.
Publicado: (2021)

Efficacy and Tolerability of Clozapine versus Quetiapine in Treatment-resistant Schizophrenia
por: Kumar, Mitesh, et al.
Publicado: (2017)

Application of Plasma Levels of Olanzapine and N-Desmethyl-Olanzapine to Monitor Clinical Efficacy in Patients with Schizophrenia
por: Lu, Mong-Liang, et al.
Publicado: (2016)

Cross-reaction of angioedema with clozapine, olanzapine, and quetiapine: A case report
por: Williams, Gabriela D.
Publicado: (2019)

Adverse Drug Reactions of Olanzapine, Clozapine and Loxapine in Children and Youth: A Systematic Pharmacogenetic Review
por: Merino, Diane, et al.
Publicado: (2022)

Clozapine Pharmacogenetic Studies in Schizophrenia: Efficacy and Agranulocytosis
por: Numata, Shusuke, et al.
Publicado: (2018)

Effects of olanzapine treatment on lipid profiles in patients with schizophrenia: a systematic review and meta-analysis
por: Li, Rong, et al.
Publicado: (2020)

Combining samidorphan with olanzapine to mitigate weight gain as a side effect in schizophrenia treatment
por: Grywińska, Weronika B., et al.
Publicado: (2023)

High-dose olanzapine in treatment-resistant schizophrenia: a systematic review
por: Gannon, Louisa, et al.
Publicado: (2023)

Barriers to using clozapine in treatment-resistant schizophrenia: systematic review
por: Farooq, Saeed, et al.
Publicado: (2019)

Clozapine and cancer treatment: Adding to the experience and evidence
por: Deodhar, Jayita K., et al.
Publicado: (2014)

Effectiveness of clozapine in treatment-resistant schizophrenia
por: Raguraman, Janakiraman, et al.
Publicado: (2005)

Olanzapine has better efficacy compared to risperidone for treatment of negative symptoms in schizophrenia
por: Suresh Kumar, P. N., et al.
Publicado: (2016)

Olanzapine has poorer efficacy than risperidone for the treatment of the negative symptoms of schizophrenia
por: Vadlamani, Laxmi Naresh, et al.
Publicado: (2017)

Clozapine-induced Weight Loss and Stuttering in a Patient with Schizophrenia
por: Das, Soumitra, et al.
Publicado: (2018)

Clozapine as a first‐ or second‐line treatment in schizophrenia: a systematic review and meta‐analysis
por: Okhuijsen‐Pfeifer, C., et al.
Publicado: (2018)

CoMET: a protocol for a randomised controlled trial of co-commencement of METformin as an adjunctive treatment to attenuate weight gain and metabolic syndrome in patients with schizophrenia newly commenced on clozapine
por: Siskind, Dan, et al.
Publicado: (2018)

Difference between treatment-resistant schizophrenia and clozapine-resistant schizophrenia
por: Tseng, Ping-Tao, et al.
Publicado: (2022)

Impact of race on efficacy and safety during treatment with olanzapine in schizophrenia, schizophreniform or schizoaffective disorder
por: Stauffer, Virginia L, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_dsrfi738g280k4o4aq5fj4br8i